Introduction
Hip fractures are a major public health problem due to functional impairment, reduced quality of life, pain and disability [1] . For a substantial proportion of sufferers, these functional limitations necessitate a move from independent accommodation to a nursing home, a change that may lead to reduced social interaction, emotional distress, reduced self-confidence and loss of dignity [2] . Activity restriction and anxiety due to the fear of falling are also common [3] [4] [5] . Furthermore, the risk of death is raised for several years following a hip fracture [6, 7] . Osteoporosis is the major risk factor for hip fractures. This condition is more common in the older age groups; hence, the risk of hip fracture is greater among the elderly and is likely to increase with the ageing of the population.
The number and rate of hospital admissions for hip fracture increased during the 1980s in Australia [8, 9] . Boufous et al. noted that the age-standardised hip fracture rate in New South Wales had stabilised over the period 1990 to 2000 [10] . Recent Victorian data show the agestandardised incidence of fall-related hip fracture hospitalisations decreased from 600/100,000 in 1998/1999 to 467/ 100,000 in 2008/2009-an estimated overall reduction of 25 % and occurred in both women and men [11] . However, Sanders et al. predicted that, even if the age-specific incidence of hip fracture observed in 1994-1995 remains constant into the future, population ageing would result in the overall number of hip fractures increasing by 36 % between 1996 and 2006, and more than doubling by 2026 [12] .
The aims of this study were to:
1. Describe the incidence of minimal trauma hip fracture in Australia over the decade 1997-1998 to 2006-2007; 2. Determine whether the observed trend varies with age and/or sex; 3. Compare the observed number of cases with that which would have been expected had the rates in 1997-1998 remained stable over the following 9 years; and 4. Investigate changes in the use of bisphosphonates over the period, as a potential influence on hip fracture incidence.
Methods
Data on incident hip fractures were obtained from the National Hospital Morbidity Database for the period June 1997 to June 2007. Virtually all hip fractures require hospital care, and thus hospital separations data can be used to reliably estimate the incidence of hip fracture. This study was restricted to people aged 50 years and over, as minimal trauma hip fractures are uncommon before that age [13] .
Data sources and data extraction
The National Hospital Morbidity Database, maintained at the Australian Institute of Health and Welfare, covers virtually all public and private hospitals in Australia [14] . The information is not person-based; instead, it relates to episodes of care in a hospital, also known as 'hospital separations'. To reduce double counting of multiple episodes of care relating to a single event, separations following a transfer from another hospital were excluded, as proposed by Kreisfeld and Newson [15] . Cases of minimal trauma hip fracture were identified by selecting separations where the principal diagnosis was fracture of the upper femur (ICD-10-AM codes S720, S721 and S722) and the external cause code indicated a low-trauma event (ICD-10-AM codes W00, W01, W03-W08, W18, W19, W22, W50, W51, and W548). For the years 1997-1998 and 1998-1999, a different coding system was in place, namely ICD-9-AM. The code for fracture of the upper femur under ICD-9-AM (code 820) mapped directly to the ICD-10-AM codes. The majority of external cause codes indicating a low-trauma event under ICD-9-AM (codes E8801, E8842-E8846, E885, E8869, E887, E888, E9173, E9174 and E9177-E9179) could be mapped directly to the ICD-10-AM codes. However, code W548 in ICD-10-AM had no equivalent in the older system, and codes 887 and 8801 in ICD-9-AM had no equivalent in the newer system. The difference in the set of external cause codes is expected to contribute a 3 % decrease in the number of fractures from 1999 to 2000 onwards.
An estimate of the June 2001 Australian population by 5-year age group was used to directly age-standardise the incidence in the comparison with the trend over time for males and females [16] . Data on the number of subsidised prescriptions for bisphosphonates dispensed in Australia between 1997 and 2007 were obtained from Medicare Australia via the Pharmaceutical Benefits Scheme online database [17] .
Statistical analyses
Annual (financial year) incidence rates for minimal trauma hip fracture were calculated using the hospital separation data and Australian population estimates [16] . The trends in agespecific rates by sex over the time period were calculated. The trends in the rates for males compared with females were directly age-standardised to the June 2001 Australian population. A simple linear regression was applied to the trends in incidence, and the slope of the line was used to determine whether each trend was statistically significant [18] . The results were extracted and analysed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA), Hyperion System 9 BI+ Interactive Reporting Studio (Oracle Corporation, Redwood Shores, CA, USA) and Microsoft Excel 2003.
Results

Incidence rates
Among Australians aged 50 years and over, the agestandardised hip fracture rate declined significantly between 1997-1998 and 2006-2007, by 20 % in females (from 370 to 295 per 100,000; p<0.001) and by 13 % in males (from 200 to 174 per 100,000; p<0.001) (Fig. 1 ). The rate in females was consistently higher than in males, but this difference decreased between 1997-1998 and 2006-2007 (p00.003). The rate in females was 85 % higher than in males in 1997-1998, but by 2006-2007 was only 70 % higher.
The incidence rate was stable in those aged 50-59 years but decreased significantly among those aged 60-89 years. However, there was a significant increase in incidence rates among males aged 90-94 years (from 1,859 to 2,256 per 100,000; p00.049) and among both males and females aged 95 years and over (from 2,619 to 3,495 per 100,000 in males, p00.008; and from 3,289 to 3,780 per 100,000 in females, p00.005) (Figs. 2 and 3) . Although the latter age group is theoretically open ended, there was no change in the average age at hip fracture within this group over the period.
The incidence rate in females was higher than in males at all ages except among those aged 95 years and over, where the rates were similar between the sexes (Fig. 4) . For other age groups in 2006-2007, the rate in females ranged from 37 to 115 % higher than in males, with the difference being largest in the 65-69-year-old age group and generally decreased thereafter.
Number of cases
An estimated 16,412 hip fracture cases occurred in 2006-2007 (4,443 in males and 11,969 in females). This represented an 11 % increase over 1997-1998 (p<0.001), when there were 14,769 cases (3,631 in males and 11,138 in females). The proportion of cases that occurred in males increased slightly but significantly over the 10-year period, from 24.6 to 27.1 % (p<0.001). The overall rise was driven by increased numbers of cases in the oldest age groups. The number of cases among those aged 80-89 years increased by around one third, while the number among those aged 90 years or over more than doubled. Numbers among those aged 50-79 years either remained stable or decreased slightly.
Had the incidence rates observed in 1997-1998 remained constant over the following 9 years, an estimated 19,241 (Fig. 5) , approximately 3,000 more hip fractures than were actually observed. These projections were more valid for males than for females.
Discussion
Our study is the first to produce national age-standardised hip fracture rates using national registry data, as other studies have extrapolated rates determined within specific regions across the country. We demonstrate significant decreases in national age-standardised hip fracture rates for both men and women between 1997-1998 and 2006-2007. The decline was seen across most age groups, with the exception of those aged 50-59 years (among whom rates were stable) and males aged 90-94 years as well as those aged 95 years and over (among whom the rates increased). We also observed a greater decrease in age-standardised hip fracture incidence among females compared with males.
The observation of overall decreases in fracture rates are consistent with observations from America [19] , Canada [20] , New Zealand [21] and several European countries [22] [23] [24] and observations from Victoria over a similar period [11] , which demonstrate both a decrease in the agestandardised incidence of fall-related hip fracture hospitalisations [11] and hip fracture rates [25] . However, our observations contrast sharply with previous Australian studies that reported an increasing trend in age-standardised hip fracture rates prior to 1990 [8, 9] and a stabilisation between 1990 and 2000 [10, 26] .
The greater decrease in age-standardised hip fracture incidence among females compared with males also mirrors overseas trends [19] [20] [21] [22] [23] [24] . The generally lower prevalence of osteoporosis in males, coupled with the perception that males are at low risk of the condition [27] , may have reduced awareness and so decreased the uptake of strategies to prevent osteoporosis and fractures in males.
Despite the decreasing age-standardised incidence rates, the absolute number of hip fractures has continued to rise The period of an earlier study from New South Wales (NSW) overlaps with the first 3 years of our study period. There are two reasons why our data differ. Firstly, we only included hip fractures where the external cause code indicated a minimal trauma event. This accounts for our lower hip fracture rates. Secondly, their data are from NSW hospitals, while our data are from all Australian hospitals. This probably accounts for the small difference in trend over the 3 years-in their data, the male and female rates are steady over the 3 years, while in our data, the male rate is steady but the female rate decreases.
Several explanations can be offered for our observed decrease in age-standardised hip fracture incidence.
Foremost among these are increasing availability and uptake of bisphosphonate medications and the success of public health campaigns aimed at osteoporosis awareness and at falls and fracture prevention [10, [19] [20] [21] [22] . Other potential influences include the widespread use of hormone replacement therapy in the past, the increase in average body mass index, increased use of calcium and vitamin D supplements and reduced prevalence of smoking [10, 21] .
Almost 3.4 million subsidised prescriptions for bisphosphonates were filled in 2007, for an estimated 300,000 users [28] . This represented a 7 % increase on the previous year, and a 30-fold increase since 1997, when around 108,000 subsidised prescriptions were filled (Fig. 6) . If one assumes that the hip fracture incidence in bisphosphonate users is 1 % per annum and that bisphosphonates reduce hip fracture incidence by an average of 30 % [27, 28] , then one can estimate a reduction in hip fracture numbers of around 1,000 per annum. The lack of a decline in older subjects may reflect less access to or willingness to prescribe or take medication for osteoporosis in this age group. In the largest US survey, the age-adjusted incidence of hip fractures in women increased by 9 % from 1986 to 1995, with a dramatic subsequent decline of 24.5 % between 1996 and 2005 [19] . A similar pattern was observed among men, with a 16.4 % rise over the initial decade studied, followed by a 19.2 % decline in the second 10-year period.
The impact of pharmacotherapy with bisphosphonates on fracture incidence rates was calculated to be 40 % in this study.
In contrast to the majority of age groups in our study, the oldest old (males aged 90-94 years and those aged 95 years and over) experienced an increasing rate of hip fracture over the study period. This result suggests that medical or public health initiatives which are successful in younger patients are either less effective or less commonly applied in very elderly patients, or that this group is at even higher risk than younger patients (e.g. due to comorbidity or increased rates of falls). Alternatively, this result may indicate a postponement of the fractures avoided in the younger age groups, fracture of a second hip or a cohort effect.
The major strength of this study was the use of national data sources that cover the entire Australian population. The National Hospital Morbidity Database covers almost every hospital in the country, and the likelihood of capturing all hip fracture cases is high. The main limitation to this method is the potential for overcounting due to multiple records being generated when a person is transferred from one hospital to another. As recommended by Kreisfeld and Newson [15] , we attempted to account for this by excluding separations with an admission mode of 'transfer from an (other) acute hospital', but it is possible that some secondary separations were still counted as incident cases. Although the effect of this would have been to produce inflated estimates of hip fracture incidence, the amount of overestimation could have varied over time, so the impact on our results is not clear. As noted above, the difference in the set of external cause codes is expected only to contribute a 3 % decrease in the number of fractures from 1999 to 2000 onwards, far less than the observed decrease. Further, the Pharmaceutical Benefits Scheme online database only contains information on subsidised medications. For bisphosphonates, however, information on community or private prescription numbers [29] suggests that only less than 1 % of prescriptions for these drugs would not have been subsidised.
In summary, the age-standardised hip fracture incidence in Australia is declining, but the absolute number of fractures continues to increase due to population ageing. Thus, the Sanders et al. predictions of a tripling in hip fracture numbers by 2036 [12] seems unlikely to eventuate. However, this decline will need to be sustained to compensate for the continued increase in the size of the population at risk of hip fracture due to ageing. Of particular concern is the substantial rise in hip fracture rates among males aged 90-94 years and those aged 95 years and over. The higher level of care often required by the very elderly may result in a substantial increase in the burden hip fractures impose on health services should this trend continue and as the number of people in this age group increases. Although there remains room for improvement in both sexes, the difference in incidence trends between males and females suggests there is a strong incentive to increase both osteoporosis awareness and the uptake of fracture prevention strategies among older Australian men.
